Quercetin does appear to lower blood sugar, but the effect is modest. A meta-analysis of randomized controlled trials found that quercetin supplementation reduced fasting blood glucose by about 1 mg/dL on average. That’s a real, statistically significant change, but it’s not dramatic enough to replace medication or make a major dent on its own. Where quercetin gets more interesting is in its effects on long-term blood sugar control and insulin resistance, especially at the right dose and duration.
How Quercetin Affects Blood Sugar
Quercetin works on blood sugar through several different pathways, which is part of why researchers find it promising even when the headline numbers look small. One of the most important effects is improving how your cells respond to insulin. In insulin-resistant cells, the signal that tells them to absorb glucose from the bloodstream gets blunted. Quercetin appears to restore that signaling, helping muscle cells pull glucose out of the blood more efficiently. It does this partly by activating a pathway called AMPK, which triggers glucose transporters to move to the cell surface, essentially opening more doors for sugar to enter.
Quercetin also slows down carbohydrate digestion. It inhibits the enzymes in your gut that break starch into simple sugars, which means glucose enters your bloodstream more gradually after a meal rather than in a sharp spike. This is the same basic mechanism that some prescription diabetes medications use.
On top of that, quercetin seems to help the pancreas. Animal and cell studies show it can promote insulin secretion from beta cells and reduce the inflammatory damage that contributes to their decline over time.
What Clinical Trials Actually Show
The fasting blood glucose reduction of roughly 1 mg/dL from meta-analyses tells only part of the story. When researchers looked more closely, the benefit depended heavily on dose and duration. Studies using 500 mg per day or more saw a meaningful reduction in fasting glucose, while lower doses often showed no significant effect. Similarly, trials lasting at least eight weeks produced significant results, while shorter ones did not. Duration also correlated with the size of the benefit, meaning longer supplementation periods tended to produce larger reductions.
A randomized controlled trial in people with type 2 diabetes found more encouraging results for long-term blood sugar control. After eight months of quercetin supplementation, participants saw their HbA1c (a measure of average blood sugar over two to three months) drop by 4% relative to their starting value, going from an average of 7.06% down to 6.78%. The control group’s HbA1c didn’t change at all. That shift is clinically meaningful and suggests quercetin’s real value may show up over months rather than days.
Insulin levels also responded to supplementation. In studies enrolling participants under age 45, quercetin at 500 mg per day or more significantly reduced circulating insulin, a sign that the body was becoming more sensitive to the insulin it was already producing rather than needing to pump out extra.
Insulin Resistance and HOMA-IR
Animal research provides a clearer picture of quercetin’s effect on insulin resistance, partly because researchers can control diets and conditions more tightly. In diabetic mice, ten weeks of quercetin supplementation significantly lowered fasting blood glucose, circulating insulin, and HOMA-IR scores (a standard measure of insulin resistance). It also reduced markers of gut inflammation and repaired intestinal barrier function, which matters because a “leaky gut” can drive the chronic low-grade inflammation that worsens insulin resistance.
Human data on insulin resistance is less robust but points in the same direction. Cell studies using human fat cells show that quercetin blocks a specific inflammatory signal (TNF-alpha) that interferes with insulin signaling. This suggests quercetin may be especially relevant for people whose blood sugar problems are driven by chronic inflammation, which describes a large portion of people with metabolic syndrome.
Dose, Duration, and Absorption
Based on the available trial data, the threshold for a blood sugar benefit appears to be around 500 mg per day taken for at least eight weeks. Below that dose or shorter than that timeframe, results in clinical trials were inconsistent.
One major challenge with quercetin is that your body absorbs very little of it in its standard form. A pharmacokinetic study in healthy volunteers compared plain quercetin to a phytosome formulation (quercetin bound to sunflower lecithin, a food-grade fat). At the same 500 mg dose, the phytosome version achieved peak blood levels about 20 times higher than unformulated quercetin. Total absorption was roughly 18 times greater. This means that 250 mg of the phytosome form delivered a similar blood concentration to 500 mg of standard quercetin.
If you’re choosing a supplement specifically for blood sugar support, the form matters. Standard quercetin powder in a capsule is poorly absorbed, and you may not reach the blood levels seen in studies showing benefits. Phytosome or lecithin-bound formulations are significantly more bioavailable. Some products also pair quercetin with bromelain or vitamin C to enhance absorption, though the evidence for those combinations is less precise.
Quercetin-Rich Foods vs. Supplements
Quercetin is found naturally in onions (especially red onions), apples, berries, capers, broccoli, and green tea. A typical Western diet provides somewhere between 10 and 100 mg of quercetin per day, depending on fruit and vegetable intake. That’s well below the 500 mg threshold that produced significant blood sugar effects in trials. You’d need to eat several pounds of onions daily to approach supplement-level doses.
That said, quercetin-rich foods come packaged with fiber, other polyphenols, and nutrients that collectively support blood sugar regulation through mechanisms beyond quercetin alone. Eating more of these foods is worthwhile for metabolic health, but if your goal is to replicate the effects seen in clinical studies, supplementation is the practical route.
Combining Quercetin With Diabetes Medication
Animal research has explored what happens when quercetin is combined with metformin, the most commonly prescribed type 2 diabetes drug. In diabetic rats, the combination produced a greater reduction in blood glucose than either substance alone. The pairing also showed protective effects on the kidneys, liver, and blood vessels that exceeded what either treatment achieved independently. Researchers described the interaction as synergistic rather than simply additive.
No long-term human studies have tested this combination, so the clinical picture is incomplete. The animal data is encouraging, but it also raises a practical concern: if quercetin genuinely enhances metformin’s glucose-lowering effect, combining the two without adjusting medication could theoretically increase the risk of blood sugar dropping too low. If you take metformin or insulin, it’s worth monitoring your blood sugar more closely when starting quercetin and discussing the addition with your prescriber.
Kidney and Liver Considerations
Quercetin is metabolized in the intestines, liver, and kidneys, and it tends to accumulate in those organs. Rather than being a concern, this may actually be beneficial. Animal studies show that quercetin-treated mice had improved kidney function and reduced kidney fibrosis (scarring). An early-phase human trial in patients with diabetic kidney disease found that a quercetin-containing regimen reduced markers of cellular aging in just 11 days, though that study used quercetin in combination with another drug and was very small.
At doses used in clinical trials (up to 1,000 mg per day), quercetin has not raised significant safety concerns for liver or kidney function. It’s generally well tolerated, with digestive discomfort being the most commonly reported side effect. However, most trials have lasted only a few months, so data on supplementation beyond a year is limited.